Research Study

A Multi-center, Open-label, Uncontrolled, Single-arm, Extension Study to Determine the Long-term Safety and Tolerability of Oral Lucerastat in Adult Subjects With Fabry Disease
Principal Investigator 
Sandra Sirrs

Overview

Disorders and Conditions 
Metabolic Disorders
ClinicalTrials.gov# 
NCT03737214
Status 
Recruiting
Study Start/End 
Dec 4, 2019 to May 22, 2022
Locations 
Diamond Health Care Centre
Name/Title 
Anita Thomas, Research Coordinator
Phone 
604-875-3806
Email Address 
athomas2@cw.bc.ca
Purpose of Study 

The purpose of this study is to determine the long-term safety and tolerability of oral lucerastat in adult subjects with Fabry disease.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.